<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ling C</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>NCATS NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NIDCD NIH HHS</funding><funding>NIDCD</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>National Institute on Deafness and Other Communication Disorders (NIDCD)</funding><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><pagination>314ra187</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4669060</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(314)</volume><pubmed_abstract>Patients with voice impairment caused by advanced vocal fold (VF) fibrosis or tissue loss have few treatment options. A transplantable, bioengineered VF mucosa would address the individual and societal costs of voice-related communication loss. Such a tissue must be biomechanically capable of aerodynamic-to-acoustic energy transfer and high-frequency vibration and physiologically capable of maintaining a barrier against the airway lumen. We isolated primary human VF fibroblasts and epithelial cells and cocultured them under organotypic conditions. The resulting engineered mucosae showed morphologic features of native tissue, proteome-level evidence of mucosal morphogenesis and emerging extracellular matrix complexity, and rudimentary barrier function in vitro. When grafted into canine lary</pubmed_abstract><journal>Science translational medicine</journal><pubmed_title>Bioengineered vocal fold mucosa for voice restoration.</pubmed_title><pmcid>PMC4669060</pmcid><funding_grant_id>T32 DC009401</funding_grant_id><funding_grant_id>TL1 TR000429</funding_grant_id><funding_grant_id>T32 GM081061</funding_grant_id><funding_grant_id>R01 DC004428</funding_grant_id><funding_grant_id>R01 DC010777</funding_grant_id><funding_grant_id>R01 AI066219</funding_grant_id><funding_grant_id>P30 CA014520</funding_grant_id><funding_grant_id>T32DC009401</funding_grant_id><funding_grant_id>P30CA014520</funding_grant_id><funding_grant_id>UL1 TR000427</funding_grant_id><pubmed_authors>Choi KO</pubmed_authors><pubmed_authors>Gunasekaran S</pubmed_authors><pubmed_authors>Nishimoto K</pubmed_authors><pubmed_authors>Welham NV</pubmed_authors><pubmed_authors>Frey BL</pubmed_authors><pubmed_authors>Li Q</pubmed_authors><pubmed_authors>Jiang JJ</pubmed_authors><pubmed_authors>Ling C</pubmed_authors><pubmed_authors>Kishimoto Y</pubmed_authors><pubmed_authors>Burlingham WJ</pubmed_authors><pubmed_authors>Smith LM</pubmed_authors><pubmed_authors>Toya Y</pubmed_authors><pubmed_authors>Devine EE</pubmed_authors><pubmed_authors>Norman IG</pubmed_authors><pubmed_authors>Tsegyal T</pubmed_authors><pubmed_authors>Brown ME</pubmed_authors></additional><is_claimable>false</is_claimable><name>Bioengineered vocal fold mucosa for voice restoration.</name><description>Patients with voice impairment caused by advanced vocal fold (VF) fibrosis or tissue loss have few treatment options. A transplantable, bioengineered VF mucosa would address the individual and societal costs of voice-related communication loss. Such a tissue must be biomechanically capable of aerodynamic-to-acoustic energy transfer and high-frequency vibration and physiologically capable of maintaining a barrier against the airway lumen. We isolated primary human VF fibroblasts and epithelial cells and cocultured them under organotypic conditions. The resulting engineered mucosae showed morphologic features of native tissue, proteome-level evidence of mucosal morphogenesis and emerging extracellular matrix complexity, and rudimentary barrier function in vitro. When grafted into canine lary</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Nov</publication><modification>2026-05-05T16:21:38.3Z</modification><creation>2019-03-27T02:04:34Z</creation></dates><accession>S-EPMC4669060</accession><cross_references><pubmed>26582902</pubmed><doi>10.1126/scitranslmed.aab4014</doi></cross_references></HashMap>